This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
LAE-32: Difference between revisions
>MmmLysergamides Working on LAE-32 Page. |
>MmmLysergamides Working on LAE-32 Page. |
||
| Line 1: | Line 1: | ||
{{SummarySheet}} | {{SummarySheet}} | ||
{{SubstanceBox | {{SubstanceBox | ||
<!-- Special Parameters --> | |||
|displayClasses={{{displayClasses|}}} | |||
|MaterialTable_MaxWidth=250px | |||
|MaterialTable_Title={{PAGENAME}} | |||
<!-- Modules --> | |||
|ModuleSource=false | |||
|ModuleCombination=false | |||
|ModuleStructure=true | |||
|ModuleNomenclature=true | |||
|ModuleClassMembership=true | |||
|ModuleROA=true | |||
<!-- Source --> | |||
|PhotoImageFile= | |||
|PhotoImageWidth= | |||
|PhotoImageCaption= | |||
<!-- Combination --> | |||
|CombinationImage1_Caption= | |||
|CombinationImage1_File= | |||
|CombinationImage1_Width= | |||
|CombinationImage2_Caption= | |||
|CombinationImage2_File= | |||
|CombinationImage2_Width= | |||
|CombinationImage3_Caption= | |||
|CombinationImage3_File= | |||
|CombinationImage3_Width= | |||
<!-- Structure --> | |||
|MolecularStructureCaption=Molecular structure of lysergic acid ethylamide | |||
|SkeletalImageFile=File:154px-LAE-32.svg.png | |||
|SkeletalImageWidth=245px | |||
|3DImageFile= | |||
|3DImageWidth= | |||
<!-- Nomenclature --> | |||
|NameCommon=LAE-32, LAE | |||
|NameSubstitution=d-Lysergic acid ethylamide | |||
|NameSystematic=N-ethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | |||
<!-- Class Membership --> | |||
|EffectClass=[[psychoactive class::Psychedelic]] | |||
|ChemicalClass=[[chemical class::Lysergamide]] | |||
<!-- Dosage/Duration per ROA --> | |||
|OralROA=false | |||
|OralROA_Collapsed=true | |||
|OralROA_Caption= | |||
|OralROA_Bioavailability= | |||
|OralROA_Threshold= | |||
|OralROA_Light= | |||
|OralROA_Common= | |||
|OralROA_Strong= | |||
|OralROA_Heavy= | |||
|OralROA_TimelineFile= | |||
|OralROA_TimelineWidth= | |||
|OralROA_Duration= | |||
|OralROA_Onset= | |||
|OralROA_Comeup= | |||
|OralROA_Peak= | |||
|OralROA_Offset= | |||
|OralROA_Aftereffects= | |||
|SublingualROA=true | |||
|SublingualROA_Collapsed=false | |||
|SublingualROA_Caption= | |||
|SublingualROA_Bioavailability= | |||
|SublingualROA_Microdose= | |||
|SublingualROA_Threshold=[[Sublingual threshold dose::0.5-1.5]] [[Sublingual dose units::mg]] | |||
|SublingualROA_Light= | |||
|SublingualROA_Common= | |||
|SublingualROA_Strong= | |||
|SublingualROA_Heavy= | |||
|SublingualROA_TimelineFile= | |||
|SublingualROA_TimelineWidth= | |||
|SublingualROA_Duration= | |||
|SublingualROA_Onset= | |||
|SublingualROA_Comeup= | |||
|SublingualROA_Peak= | |||
|SublingualROA_Offset= | |||
|SublingualROA_Aftereffects= | |||
|BuccalROA=false | |||
|BuccalROA_Collapsed=true | |||
|BuccalROA_Caption=Presumes no tolerance | |||
|BuccalROA_Bioavailability= | |||
|BuccalROA_Threshold=< x mg | |||
|BuccalROA_Light=x - x mg | |||
|BuccalROA_Common=x - x mg | |||
|BuccalROA_Strong=x - x mg | |||
|BuccalROA_Heavy= > mg | |||
|BuccalROA_TimelineFile= | |||
|BuccalROA_TimelineWidth= | |||
|BuccalROA_Duration=x - x hours | |||
|BuccalROA_Onset=x minutes | |||
|BuccalROA_Peak=x hours | |||
|BuccalROA_Offset=x hours | |||
|BuccalROA_Aftereffects=x hours | |||
|InsufflatedROA=false | |||
|InsufflatedROA_Collapsed=true | |||
|InsufflatedROA_Caption= | |||
|InsufflatedROA_Bioavailability= | |||
|InsufflatedROA_Threshold=< x mg | |||
|InsufflatedROA_Light=x - x mg | |||
|InsufflatedROA_Common=x - x mg | |||
|InsufflatedROA_Strong=x - x mg | |||
|InsufflatedROA_Heavy= > mg | |||
|InsufflatedROA_TimelineFile= | |||
|InsufflatedROA_TimelineWidth= | |||
|InsufflatedROA_Duration=x - x hours | |||
|InsufflatedROA_Onset=x minutes | |||
|InsufflatedROA_Peak=x hours | |||
|InsufflatedROA_Offset=x hours | |||
|InsufflatedROA_Aftereffects=x hours | |||
|RectalROA=false | |||
|RectalROA_Collapsed=true | |||
|RectalROA_Caption=Presumes no tolerance | |||
|RectalROA_Bioavailability= | |||
|RectalROA_Threshold=< x mg | |||
|RectalROA_Light=x - x mg | |||
|RectalROA_Common=x - x mg | |||
|RectalROA_Strong=x - x mg | |||
|RectalROA_Heavy= > mg | |||
|RectalROA_TimelineFile= | |||
|RectalROA_TimelineWidth= | |||
|RectalROA_Duration=x - x hours | |||
|RectalROA_Onset=x minutes | |||
|RectalROA_Peak=x hours | |||
|RectalROA_Offset=x hours | |||
|RectalROA_Aftereffects=x hours | |||
|TransdermalROA=false | |||
|TransdermalROA_Collapsed=true | |||
|TransdermalROA_Caption=Presumes no tolerance | |||
|TransdermalROA_Bioavailability= | |||
|TransdermalROA_Threshold=< x mg | |||
|TransdermalROA_Light=x - x mg | |||
|TransdermalROA_Common=x - x mg | |||
|TransdermalROA_Strong=x - x mg | |||
|TransdermalROA_Heavy= > mg | |||
|TransdermalROA_TimelineFile= | |||
|TransdermalROA_TimelineWidth= | |||
|TransdermalROA_Duration=x - x hours | |||
|TransdermalROA_Onset=x minutes | |||
|TransdermalROA_Peak=x hours | |||
|TransdermalROA_Offset=x hours | |||
|TransdermalROA_Aftereffects=x hours | |||
|SubcutaneousROA=false | |||
|SubcutaneousROA_Collapsed=true | |||
|SubcutaneousROA_Caption=Presumes no tolerance | |||
|SubcutaneousROA_Bioavailability= | |||
|SubcutaneousROA_Threshold=< x mg | |||
|SubcutaneousROA_Light=x - x mg | |||
|SubcutaneousROA_Common=x - x mg | |||
|SubcutaneousROA_Strong=x - x mg | |||
|SubcutaneousROA_Heavy= > mg | |||
|SubcutaneousROA_TimelineFile= | |||
|SubcutaneousROA_TimelineWidth= | |||
|SubcutaneousROA_Duration=x - x hours | |||
|SubcutaneousROA_Onset=x minutes | |||
|SubcutaneousROA_Peak=x hours | |||
|SubcutaneousROA_Offset=x hours | |||
|SubcutaneousROA_Aftereffects=x hours | |||
|IntramuscularROA=false | |||
|IntramuscularROA_Collapsed=true | |||
|IntramuscularROA_Caption=Presumes no tolerance | |||
|IntramuscularROA_Bioavailability= | |||
|IntramuscularROA_Threshold=< x mg | |||
|IntramuscularROA_Light=x - x mg | |||
|IntramuscularROA_Common=x - x mg | |||
|IntramuscularROA_Strong=x - x mg | |||
|IntramuscularROA_Heavy= > mg | |||
|IntramuscularROA_TimelineFile= | |||
|IntramuscularROA_TimelineWidth= | |||
|IntramuscularROA_Duration=x - x hours | |||
|IntramuscularROA_Onset=x minutes | |||
|IntramuscularROA_Peak=x hours | |||
|IntramuscularROA_Offset=x hours | |||
|IntramuscularROA_Aftereffects=x hours | |||
|IntravenousROA=false | |||
|IntravenousROA_Collapsed=true | |||
|IntravenousROA_Caption=Presumes no tolerance | |||
|IntravenousROA_Bioavailability= | |||
|IntravenousROA_Threshold=< x mg | |||
|IntravenousROA_Light=x - x mg | |||
|IntravenousROA_Common=x - x mg | |||
|IntravenousROA_Strong=x - x mg | |||
|IntravenousROA_Heavy= > mg | |||
|IntravenousROA_TimelineFile= | |||
|IntravenousROA_TimelineWidth= | |||
|IntravenousROA_Duration=x - x hours | |||
|IntravenousROA_Onset=x minutes | |||
|IntravenousROA_Peak=x hours | |||
|IntravenousROA_Offset=x hours | |||
|IntravenousROA_Aftereffects=x hours | |||
}} | |||
'''Lysergic acid ethylamide''' (also known as '''LAE-32''', '''LAE''', and '''d-ethyllysergamide''') is a semisynthetic [[psychoactive class::psychedelic]] substance of the [[chemical class::lysergamide]] class. | '''Lysergic acid ethylamide''' (also known as '''LAE-32''', '''LAE''', and '''d-ethyllysergamide''') is a semisynthetic [[psychoactive class::psychedelic]] substance of the [[chemical class::lysergamide]] class. | ||
LAE-32 is one of the least known and least researched psychedelic substances. | LAE-32 is one of the least known and least researched psychedelic substances. | ||
The pharmacology of LAE-32 is complex, but it acts primarily by binding to [[serotonin]] [[receptors]] in the brain, much like LSD and other serotonergic psychedelics.{{citation needed}} | The pharmacology of LAE-32 is complex, but it acts primarily by binding to [[serotonin]] [[receptors]] in the brain, much like LSD and other serotonergic psychedelics.{{citation needed}} | ||